mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |